Viyash Scientific Limited - Asset Resilience Ratio

Latest as of September 2025: 0.08%

Viyash Scientific Limited (SEQUENT) has an Asset Resilience Ratio of 0.08% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

Rs14.50 Million

≈ $156.81K USD Cash + Short-term Investments

Total Assets

Rs17.26 Billion

≈ $186.67 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2006–2025)

This chart shows how Viyash Scientific Limited's Asset Resilience Ratio has changed over time. Check SEQUENT PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Viyash Scientific Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Viyash Scientific Limited (SEQUENT) total market value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs14.50 Million	0.08%
Total Liquid Assets	Rs14.50 Million	0.08%

Asset Resilience Insights

Limited Liquidity: Viyash Scientific Limited maintains only 0.08% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Viyash Scientific Limited Industry Peers by Asset Resilience Ratio

Compare Viyash Scientific Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Sandoz Group AG SW:SDZ	Drug Manufacturers - Specialty & Generic	7.89%
Viatris Inc NASDAQ:VTRS	Drug Manufacturers - Specialty & Generic	1.62%
China Resources Sanjiu Medical & Pharmaceutical Co Ltd SHE:000999	Drug Manufacturers - Specialty & Generic	5.22%
Humanwell Healthcare Group Co Ltd SHG:600079	Drug Manufacturers - Specialty & Generic	2.75%
Chengdu Kanghong Pharmaceuticals Group Co Ltd SHE:002773	Drug Manufacturers - Specialty & Generic	4.31%
Regencell Bioscience Holdings Ltd NASDAQ:RGC	Drug Manufacturers - Specialty & Generic	43.05%
Avadel Pharmaceuticals PLC NASDAQ:AVDL	Drug Manufacturers - Specialty & Generic	5.90%

Annual Asset Resilience Ratio for Viyash Scientific Limited (2006–2025)

The table below shows the annual Asset Resilience Ratio data for Viyash Scientific Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	0.03%	Rs4.18 Million ≈ $45.21K	Rs16.02 Billion ≈ $173.24 Million	-0.23pp
2024-03-31	0.26%	Rs39.75 Million ≈ $429.88K	Rs15.40 Billion ≈ $166.59 Million	+0.26pp
2023-03-31	0.00%	Rs460.00K ≈ $4.97K	Rs15.29 Billion ≈ $165.37 Million	-0.11pp
2022-03-31	0.11%	Rs16.25 Million ≈ $175.74K	Rs14.51 Billion ≈ $156.92 Million	-0.32pp
2021-03-31	0.43%	Rs59.59 Million ≈ $644.44K	Rs13.93 Billion ≈ $150.60 Million	-2.32pp
2020-03-31	2.75%	Rs401.79 Million ≈ $4.35 Million	Rs14.63 Billion ≈ $158.18 Million	+2.71pp
2019-03-31	0.03%	Rs4.70 Million ≈ $50.83K	Rs13.88 Billion ≈ $150.09 Million	-1.26pp
2018-03-31	1.29%	Rs173.45 Million ≈ $1.88 Million	Rs13.43 Billion ≈ $145.21 Million	-2.14pp
2017-03-31	3.43%	Rs653.76 Million ≈ $7.07 Million	Rs19.05 Billion ≈ $205.98 Million	-0.95pp
2016-03-31	4.38%	Rs669.78 Million ≈ $7.24 Million	Rs15.28 Billion ≈ $165.26 Million	+4.32pp
2015-03-31	0.06%	Rs5.81 Million ≈ $62.83K	Rs9.08 Billion ≈ $98.16 Million	+0.05pp
2014-03-31	0.01%	Rs770.00K ≈ $8.33K	Rs6.23 Billion ≈ $67.34 Million	-0.02pp
2013-03-31	0.03%	Rs1.77 Million ≈ $19.14K	Rs5.86 Billion ≈ $63.40 Million	-0.02pp
2012-03-31	0.05%	Rs2.77 Million ≈ $29.96K	Rs5.47 Billion ≈ $59.19 Million	-0.18pp
2011-03-31	0.23%	Rs10.25 Million ≈ $110.85K	Rs4.50 Billion ≈ $48.65 Million	-4.31pp
2006-03-31	4.54%	Rs12.46 Million ≈ $134.71K	Rs274.60 Million ≈ $2.97 Million	--

pp = percentage points

About Viyash Scientific Limited

NSE:SEQUENT India Drug Manufacturers - Specialty & Generic

Market Cap

$529.07 Million

Rs48.92 Billion INR

Market Cap Rank

#11999 Global

#594 in India

Share Price

Rs193.72

Change (1 day)

-3.70%

52-Week Range

Rs168.04 - Rs252.00

All Time High

Rs322.89